CMPS Overview
Upcoming Projects (CMPS)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (CMPS)
-
Discussing therapeutics for MDD/TRD with a focus on psilocybin based therapies - 2nd look
Tickers: CMPS, XENE, NMRA, JNJ
Executed On: Feb 09, 2024 at 02:00 PM EST -
Discussing therapeutics for MDD/TRD with a focus on psilocybin based therapies
Tickers: CMPS, XENE, NMRA, JNJ
Executed On: Feb 01, 2024 at 03:00 PM EST -
A third look at the potential of psilocybin therapy and the Phase 2b study of COMP360 psilocybin therapy for treatment-resistant depression in The New England Journal of Medicine.
Ticker: CMPS
Executed On: Dec 01, 2022 at 11:30 AM EST -
A second look at the potential of psilocybin therapy and the Phase 2b study of COMP360 psilocybin therapy for treatment-resistant depression in The New England Journal of Medicine.
Ticker: CMPS
Executed On: Nov 22, 2022 at 09:30 AM EST -
A look at the potential of psilocybin therapy and the Phase 2b study of COMP360 psilocybin therapy for treatment-resistant depression in The New England Journal of Medicine.
Ticker: CMPS
Executed On: Nov 14, 2022 at 04:00 PM EST -
A Second Opinion: Discussing esketamine and psilocybin and their relevance in treating patients with Treatment-Resistant Depression
Tickers: JNJ, CMPS
Executed On: May 05, 2022 at 11:30 AM EDT -
Discussing esketamine and psilocybin and their relevance in treating patients with Treatment-Resistant Depression
Tickers: JNJ, CMPS
Executed On: Apr 12, 2022 at 11:00 AM EDT
Upcoming & Overdue Catalysts (CMPS)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (CMPS)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
